Article Details

Vebeglogene autotemcel by Lantu Biopharma for Beta Thalassaemia: Likelihood of Approval

Retrieved on: 2025-01-06 01:48:35

Tags for this article:

Click the tags to see associated articles and topics

Vebeglogene autotemcel by Lantu Biopharma for Beta Thalassaemia: Likelihood of Approval. View article details on hiswai:

Excerpt

Lantu Biopharma is a gene therapy company dedicated to developing novel genetic medicines and therapies. Lantu Biopharma is headquartered in China.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo